An ultrasound device that can precisely stimulate areas deep in the brain without surgery has been developed by researchers from University of Oxford’s Nuffield Department of Clinical Neurosciences (NDCN) and…
Plans to transform an NHS site into a major mental health and medical research campus in Headington have been submitted to Oxford City Council by Oxford Health NHS Foundation Trust. …
A pioneering research centre aimed at achieving better mental health outcomes for children, young people and families will be established at the University of Oxford thanks to a £27 million…
Chronic pain is life-changing and considered one of the leading causes of disability worldwide. Despite established theories about the molecular mechanisms behind it, scientists have been unable to identify the…
A major new Lancet Commission has called for people taking psychiatric medications – such as antidepressants, antipsychotics, and mood stabilisers – to receive proactive, ongoing physical health monitoring and support….
Findings from a study published today in The Lancet Public Health provide the strongest evidence to date that salt warning labels on restaurant menus are perceived by consumers as effective…
A new study has investigated whether cannabidiol (CBD), a non-intoxicating compound found in cannabis, can reduce the harmful effects of cannabis use in people with schizophrenia. The study, “Does cannabidiol…
A significant number of people who experience psychosis face long-term challenges with their mental, physical, and social health. The Early Intervention Mission is a UK-wide study aiming to improve early…
A new review published in JAMA Psychiatry explores how inflammation in the body may contribute to mental health conditions such as psychosis, depression and autism, and what this could mean for…
A drug used for Parkinson’s disease has been shown to be effective in reducing the symptoms of difficult to treat depression, in a study led by the University of Oxford….
Recent developments in psychiatry and neuroscience are shedding light on the potential of digital and pharmacological innovations to transform mental health care. Two new significant studies from the University of…
A new study by the University of Oxford published in the journal npj Vaccines, shows that a vaccine against respiratory syncytial virus (RSV) is associated with a 29% reduction in dementia risk in…
The successful parent-led programme, developed with support from the NIHR Oxford Health Biomedical Research Centre (OH BRC) and the Applied Research Collaboration Oxford and Thames Valley (ARC OxTV), is being…
New research has found that a mindfulness-based psychological therapy that incorporates elements from cognitive behavioural therapy (CBT), may help to reduce symptoms in people with difficult-to-treat depression (DTD). The paper,…
Statins deemed safe from a neuropsychiatric perspective but ineffective as antidepressants in at-risk adults, Oxford study finds. A landmark online trial published in Psychological Medicine and conducted at the University…
Researchers from the NIHR Mental Health Translational Research Collaboration (MH-TRC) Mission’s Children and Young People’s (CYP) Mental Health workstream have recently published a paper on brain stimulation in teenagers with Neurofibromatosis Type…
Recently, the NIHR Mental Health Translation Research Collaboration (MH-TRC) Mission Psychosis Network was launched to facilitate collaboration between psychosis researchers and clinicians in the UK. The network aims to facilitate…
Recently, children and young people’s (CYP) mental health researchers from the Children and Adolescents Data Resource (CADRE) network came together to discuss progress in building a national data platform for CYP…
A major new meta-analysis has found that glucagon-like peptide 1 receptor agonists (GLP1- RAs) may also offer benefits for emotional wellbeing. A major new meta-analysis led by the Institute of…
A new asthma study has found that a dose of inhaled beclomethasone, known as Clenil Modulite® or the ‘brown’ steroid inhaler in the UK, could lead to better clinical outcomes…